Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation

Epithelial ovarian cancer (EOC) has a poor prognosis and high mortality rate; patients are easy to relapse with standard therapies. So, there is an urgent need to develop novel drugs. In this study, differentially expressed genes (DEGs) of EOC were identified in The Cancer Genome Atlas (TCGA) and Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Dan, Bai, Jin, Lu, Enting, Yang, Chunjiao, Liu, Jiaqing, Wen, Zhenpeng, Liu, Xuqin, Jin, Zi, Xu, Mengdan, Jiang, Lei, Zhang, Ye, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568458/
https://www.ncbi.nlm.nih.gov/pubmed/34745968
http://dx.doi.org/10.3389/fonc.2021.745590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568458/
https://www.ncbi.nlm.nih.gov/pubmed/34745968
http://dx.doi.org/10.3389/fonc.2021.745590

Ejemplares similares